Effect of zinc supplementation on the immune status of healthy older individuals aged 55-70 years: The ZENITH study

Clare F Hodkinson, Mary Kelly, H. Denis Alexander, Ian Bradbury, Paula J Robson, Maxine P Bonham, JM O'Connor, Charles Coudray, JJ Strain, Julie MW Wallace

Research output: Contribution to journalArticle

Abstract

Aging is associated with alterations in the immune system, effects which may be exacerbated by inadequate zinc (Zn) status. We examined the relationship between Zn status and markers of immunity and the effect of supplementation with 15 mg or 30 mg Zn/d for 6 months on immune status in healthy individuals. Zn status was assessed by dietary intake and biochemical indices. Immune status was assessed by multiple flow cytometric methods. At baseline, Zn concentration was positively associated with lymphocyte subpopulation counts and T-lymphocyte activation. Zn supplementation of 30 mg/d significantly lowered B-lymphocyte count, albeit at month 3 only. Lower doses of Zn (15 mg Zn/d) significantly increased the ratio of CD4 to CD8 T lymphocytes at month 6. Overall, these findings suggest that total Zn intake (diet plus supplementation) of up to 40 mg Zn/d do not have significant long-term effects on immune status in apparently healthy persons aged 55-70 years.
Original languageEnglish
Pages (from-to)598-608
JournalJournals of Gerontology, Series A
Volume62
Issue number6
Publication statusPublished - Jun 2007

Fingerprint Dive into the research topics of 'Effect of zinc supplementation on the immune status of healthy older individuals aged 55-70 years: The ZENITH study'. Together they form a unique fingerprint.

  • Cite this

    Hodkinson, C. F., Kelly, M., Alexander, H. D., Bradbury, I., Robson, P. J., Bonham, M. P., O'Connor, JM., Coudray, C., Strain, JJ., & Wallace, J. MW. (2007). Effect of zinc supplementation on the immune status of healthy older individuals aged 55-70 years: The ZENITH study. Journals of Gerontology, Series A, 62(6), 598-608.